Recruiting Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata NCT05398809 Conditions Alopecia, Alopecia Areata, Autoimmune Diseases, +10 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
